TY  - JOUR 
AU  - Inoges, Susana
AU  - Lopez-Diaz de Cerio, Ascension
AU  - Zabalegui, Natalia
AU  - Soria, Elena
AU  - Villanueva, Helena
AU  - Panizo, Carlos
AU  - Rodríguez Caballero, María Arantzazu
AU  - Suarez, Lilia
AU  - Pastor, Fernando
AU  - Rodriguez-Calvillo, Mercedes
AU  - Orfao de Matos Correia e Vale, José Alberto
AU  - Bendandi, Maurizio
PY  - 2009
SN  - 1042-8194
SN  - 1042-8194
UR  - http://hdl.handle.net/10366/169365
AB  - [EN]During the last 2 decades, idiotypic vaccination has provided proof of principle of biological efficacy, clinical efficacy and clinical benefit in small follicular lymphoma trials. However, with the exception of anecdotal reports, most patients...
LA  - eng
PB  - Taylor and Francis
KW  - Idiotype,vaccination, follicular lymphoma,boosters
KW  - Idiotype
KW  - Vaccination
KW  - Follicular lymphoma
KW  - Boosters
KW  - Cancer Vaccines
KW  - Lymphoma
KW  - Time Factors
KW  - Immunoglobulin Idiotypes
KW  - Adult
KW  - Treatment Outcome
KW  - Follow-Up Studies
KW  - Humans
KW  - Vaccination
KW  - Middle Aged
TI  - Prolonged idiotypic vaccination against follicular lymphoma
DO  - 10.1080/10428190802601122
T2  - Leukemia & Lymphoma
VL  - 50
M2  - 47
ER  -